Retatrutide, Amycretin, Survodutide, VK2735, and MariTide are among the most watched pipeline assets heading into 2026 because each represents a different answer to the same commercial question: what comes after Ozempic, Wegovy, Mounjaro, and Zepbound
ALC can also help to maintain blood pressure levels already within normal range
Not the last Christmas
It becomes genuinely inadequate as the only strategy for patients with 50+ lbs to lose or complex metabolic conditions
Slower adjustments can help with fewer side effects but might delay reaching the full effectiveness of the medication
NMQF utilizes data and research to support and mobilize healthcare organizations, leaders, policymakers, and patients in advocating for biologically-aligned care that reduces hospitalizations, disabilities, and deaths while promoting high-quality, long lives, particularly for the most vulnerable